XERIS PHARMACEUTICALS INC's ticker is and the CUSIP is 98422LAA5. A total of 7 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243,750 | -10.4% | 250,000 | 0.0% | 0.22% | -21.5% |
| Q2 2023 | $272,172 | +2.2% | 250,000 | 0.0% | 0.28% | +69.1% |
| Q1 2023 | $266,223 | +29.0% | 250,000 | 0.0% | 0.16% | 0.0% |
| Q4 2022 | $206,400 | -11.4% | 250,000 | 0.0% | 0.16% | +73.7% |
| Q3 2022 | $233,000 | +2.6% | 250,000 | 0.0% | 0.10% | +75.9% |
| Q2 2022 | $227,000 | -21.5% | 250,000 | 0.0% | 0.05% | -20.6% |
| Q1 2022 | $289,000 | -6.8% | 250,000 | 0.0% | 0.07% | +17.2% |
| Q4 2021 | $310,000 | +4.7% | 250,000 | 0.0% | 0.06% | -44.2% |
| Q3 2021 | $296,000 | -24.5% | 250,000 | 0.0% | 0.10% | -34.6% |
| Q2 2021 | $392,000 | -7.5% | 250,000 | 0.0% | 0.16% | +50.0% |
| Q1 2021 | $424,000 | -3.4% | 250,000 | 0.0% | 0.11% | -51.2% |
| Q4 2020 | $439,000 | – | 250,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kamunting Street Capital Management, L.P. | 1,500 | $1,508,000 | 1.72% |
| Context Capital Management, LLC | 3,250,000 | $3,202,000 | 1.24% |
| Mohican Financial Management, LLC | 500,000 | $494,000 | 0.89% |
| 683 Capital Management, LLC | 10,000,000 | $10,050,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 18,000,000 | $17,732,000 | 0.52% |
| SILVERBACK ASSET MANAGEMENT LLC | 1,500,000 | $1,496,000 | 0.37% |
| Hound Partners | 2,500,000 | $2,476,000 | 0.22% |
| DeepCurrents Investment Group LLC | 6,000,000 | $6,117,000 | 0.22% |
| WHITEBOX ADVISORS LLC | 4,000,000 | $3,941,000 | 0.22% |
| Antara Capital LP | 1,500,000 | $1,485,000 | 0.16% |